Virax
  • Home
  • Trial Info
  • Corporate
  • Announcements
  • Recent Press Articles
  • Investor Information
  • Virax's Technology
  • Development Products
  • CEO Interview
  • Alpha Securities Report
Virax is developing immunotherapies that boost the immune system to treat a broad range of diseases.
  • Share price
  • Contact us
  • Subscribe
  • Convertible Note Quarterly Report 31 12 2011
    Tuesday 31 January 2012
  • Supplemental Trust Deed - Convertible Notes - 10 January 2012
    Tuesday 10 January 2012
  • Dutchess Continuous Investment Agreement - 10 January 2012
    Tuesday 10 January 2012
  • Appendix 3B - 10 January 2012
    Tuesday 10 January 2012
  • More announcements
Information Pack

To receive an updated
information pack
please contact us.

*Printer-friendly version

© Copyright Virax 2008. All rights reserved. Site index Legal Contact Us

DDSN Interactive Website Design Melbourne Australia, Web Hosting, Web Development by DDSN InteractiveVirax is built and powered by CM3